Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Select your species
Human Biglycan Kit ELISA pour Sandwich ELISA - ABIN423825
Maishi, Ohba, Akiyama, Ohga, Hamada, Nagao-Kitamoto, Alam, Yamamoto, Kawamoto, Inoue, Taketomi, Shindoh, Hida, Hida: Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan. dans Scientific reports 2016
After the first year of smoking abstinence the levels of BGN expression and carotid-femoral pulse wave velocity are significantly improved as compared to baseline.
study reports a temporal relationship between altered placental biglycan expression and subsequent development of fetal growth restriction/small for gestational age.
Quantitative polymerase chain reaction for messenger RNA expression from tissue specimens revealed significantly higher expression of Biglycan (p = 0.0008) and Lumican (Montrer LUM Kits ELISA) (p = 0.01) and lower expression of Decorin (Montrer DCN Kits ELISA) (p < 0.0001) in urothelial carcinoma of bladder
Mutation in BGN gene is associated with X-Linked Spondyloepimetaphyseal Dysplasia.
biglycan exerts an important role in cell proliferation, migration, invasion and apoptosis in colon cancer.
BGN might play an important role on metastasis in human endometrial cancer and it might be a target marker for the molecular therapy of advanced and recurrence endometrial cancer.
This study demonstrated that the small leucine-rich proteoglycan (Montrer Vcan Kits ELISA) BGN accumulates in CADASIL (Montrer NOTCH3 Kits ELISA) and binds to NOTCH3 (Montrer NOTCH3 Kits ELISA).
Biglycan may have a role in development of vascular damage in smokers
BGN is a factor secreted by peritubular cells to modulate FGFR3c signaling and thus contributes to the regulation of spermatogonial maintenance
The results suggest that regions within BGN is associated with ACL (Montrer ACLY Kits ELISA) injury susceptibility and that genetic sequence variability within genes encoding proteoglycans may potentially modulate the ligament fibril properties.
Results show that Bgn plays a role in the process of angiogenesis during fracture healing, and that effect appears to be partially mediated through endostatin (Montrer COL18A1 Kits ELISA) suppression.
Asporin (Montrer ASPN Kits ELISA) deficiency changes skin glycosaminoglycan composition, and decorin (Montrer DCN Kits ELISA) and biglycan content, which may explain the changes in skin mechanical properties.
Biglycan plays a protective role during the progression of atherosclerosis in ApoE (Montrer APOE Kits ELISA)-deficient mice by inhibiting thrombin (Montrer F2 Kits ELISA) generation.
These genes were concordantly induced by TAC (Montrer IL2RA Kits ELISA) in WT but not in biglycan KO mice. CONCLUSIONS: Left ventricular pressure overload induces biglycan expression in cardiac fibroblasts. Ablation of biglycan improves cardiac function and attenuates left ventricular hypertrophy and fibrosis after long-term pressure overload.
Importance of biglycan and decorin (Montrer DCN Kits ELISA) as targets for the manipulation of fetal membrane extracellular matrix stability in the context of inflammation.
Biglycan deficiency leads to loosely packed aortic collagen fibers, increased susceptibility of aortic elastin (Montrer ELN Kits ELISA) fibers to angII-induced stress, and up-regulation of vascular perlecan (Montrer HSPG2 Kits ELISA) content.
Biglycan signaling supported fetal membrane remodeling during early gestation in the absence of concomitant changes in TGFbeta (Montrer TGFB1 Kits ELISA) levels.
Lumican (Montrer LUM Kits ELISA) and biglycan influence corneal keratocyte lamellipodia organization and are critical in the regulation of stromal collagen fibrillogenesis.
Biglycan-triggered TLR-2 (Montrer TLR2 Kits ELISA)- and TLR-4 (Montrer TLR4 Kits ELISA)-signaling exacerbates the pathophysiology of ischemic acute kidney injury.
De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88 (Montrer MYD88 Kits ELISA)/TRIF (Montrer RNF138 Kits ELISA) pathways.
Data show that biglycan, collagen type I, collagen type II, decorin (Montrer DCN Kits ELISA), and versican (Montrer Vcan Kits ELISA) were significantly affected by vibration duration, frequency, and amplitude.
biglycan showed a unique ability to organize collagen VI into extensive hexagonal-like networks over a time period of only a few minutes
biglycan-induced fibroblast cytoskeletal and signalling changes result in an increased cell migration; potential role in the remodelling process
The results indicate that CTGF (Montrer CTGF Kits ELISA) suppresses the synthesis of biglycan but newly induced that of decorin (Montrer DCN Kits ELISA) in the cells when the cell density is low.
LDL electrostatic interactions with decorin (Montrer DCN Kits ELISA) and biglycan in the aortic valve leaflets and vascular wall is a major source of LDL retention.
Bgn regulates BMP4 (Montrer BMP4 Kits ELISA) signaling through modulation of Chordin (Montrer CHRD Kits ELISA) anti-BMP4 (Montrer BMP4 Kits ELISA) activity.
The protein encoded by this gene is a small cellular or pericellular matrix proteoglycan that is closely related in structure to two other small proteoglycans, decorin and fibromodulin. The encoded protein and decorin are thought to be the result of a gene duplication. Decorin contains one attached glycosaminoglycan chain, while this protein probably contains two chains. For this reason, this protein is called biglycan. This protein plays a role in assembly of collagen fibrils and muscle regeneration. It interacts with several proteins involved in muscular dystrophy, including alpha-dystroglycan, alpha- and gamma-sarcoglycan and collagen VI, and it is critical for the assembly of the dystrophin-associated protein complex.
, bone/cartilage proteoglycan I
, bone/cartilage proteoglycan-I
, dermatan sulphate proteoglycan I
, small leucine-rich protein 1A
, Small proteoglycan I (biglycan), bone (BSPG1) (bone/cartilage proteclycan 1 precursor)
, bone/cartilage proteclycan 1
, leucine-rich PG I